Detection of Health Risk Situations in the Anesthesia Consultation.

This study aims to estimate the proportion of patients seen in the anesthesiology consultation for planned surgery in whom a previously unknown health risk situation is detected (e.g., obesity, anemia, etc.).

Study Overview

• Status: Recruiting
• Conditions: Surgical Procedures, Operative
• Intervention / Treatment: Other: unknown health risk situation

• Study Type: Observational
• Enrollment (Estimated): 218

Contacts and Locations

• Study Contact: Name: Laura Mingüell, MD; Phone Number: 0034938960025; Email: lminguell@csapg.cat
• Study Contact Backup: Name: Noemí Casaponsa; Phone Number: 43197 0034938960025; Email: recerca@csapg.cat

Study Locations

• Spain
  • Barcelona
    • Vilafranca del Penedés, Barcelona, Spain
      • Recruiting
      • Consorci Sanitari Alt Penedès-Garraf
      • Contact: Laura Mingüell, MD; Phone Number: 0034938960025; Email: lminguell@csapg.cat
      • Contact: Noemí Casaponsa; Phone Number: 43197 0034938960025; Email: recerca@csapg.cat
      • Contact: Laura Mingüell, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Patients evaluated in person at the preoperative anesthesia consultation for a scheduled surgery indication.

Description

Inclusion Criteria:

• Men and women aged 18 to 50 years.

  • Indication for elective surgery.
  • In-person preoperative evaluation in the scheduled Anesthesiology consultation.

Exclusion Criteria:

• Indication for non-deferrable urgent surgery.
• Pregnant women.
• Pre-surgical visit outside the anesthesia consultation.
• Incomplete preoperative evaluation, as indicated in the final section (preoperative judgment) of the anesthesia visit report.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
unknown health risk situation	proportion of patients with a unknown health risk situation	1 year

Collaborators and Investigators

• Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf

Study record dates

Study Major Dates

• Study Start (Actual): February 4, 2025
• Primary Completion (Estimated): December 1, 2025
• Study Completion (Estimated): December 1, 2025

Study Registration Dates

• First Submitted: December 5, 2024
• First Submitted That Met QC Criteria: December 5, 2024
• First Posted (Actual): December 9, 2024

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: February 10, 2025
• Last Verified: February 1, 2025

More Information

Terms related to this study

• Other Study ID Numbers: CSAPG-64

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).
• IPD Sharing Time Frame: After publication of main results of the study.
• IPD Sharing Access Criteria: IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No